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Abstract
Degeneration of intervertebral discs (IVD) is one of the
main causes of back pain and tissue engineering has been
proposed as a treatment. Tissue engineering requires the
use of highly expensive growth factors, which might, in
addition, lack regulatory approval for human use. In an
effort to find readily available differentiation factors, we
tested three molecules – dexamethasone, triiodothyronine
(T3) and insulin – on human IVD cells isolated after surgery,
expanded in vitro and transferred into alginate beads.
Triplicates containing 40 ng/ml dexamethasone, 10 nM T3
and 10 g/ml insulin, together with a positive control (10
ng/mL transforming growth factor (TGF)-1), were
sampled weekly over six weeks and compared to a negative
control. Furthermore, we compared the results to cultures
with optimized chondrogenic media and under hypoxic
condition (2% O
2
). Glycosaminoglycan (GAG)
determination by alcian blue assay and histological staining
showed dexamethasone to be more effective than T3 and
insulin, but less than TGF-1. DNA quantification showed
that only dexamethasone stimulated cell proliferation. qPCR
demonstrated that TGF-1 and the optimized chondrogenic
groups increased the expression of collagen type II, while
aggrecan was stimulated in cultures containing
dexamethasone. Hypoxia increased GAG accumulation,
collagen type II and aggrecan expression, but had no effect
on or even lowered cell number. In conclusion,
dexamethasone is a valuable and cost-effective molecule
for chondrogenic and viability induction of IVD cells under
normoxic and hypoxic conditions, while insulin and T3
did not show significant differences.
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Introduction
Intervertebral disc (IVD) degeneration is a multi-factorial,
age-dependent process. Clinically, the degenerative
process can be asymptomatic, but it also may lead to acute
or chronic back pain which often ultimately is treated
surgically, with varying results in terms of effectiveness
and patient satisfaction (Borenstein et al., 2001; Lee and
Langrana, 2004; Adams et al., 2006). While the etiology
of disc degeneration is heterogeneous, the quality of the
surgically extracted degenerated tissues is mostly poor,
showing disturbance in the morphological organization
and impaired mechano-biological properties of the tissue
due to proteolytic activity and decreased proteoglycan
content (Antoniou et al., 1996). Using disc cells extracted
from such degenerated tissues represents a substantial
challenge for the biological regeneration of the disc. For
this reason, stimulation and activation of IVD cells in
culture will be a necessity for future autologous and
allogenic cell-based therapies.
Stimulation of IVD cells in vitro and in vivo have been
the focus of a number of articles that deal with the topic
of restoring the biological function of degenerated IVD
cells. In vivo therapeutic approaches were based on the
use of various natural or recombinant proteins, either
administered directly or via gene therapy (Chadderdon et
al., 2004), or in vitro by direct supplementation to cell
culture of these factors (Gruber et al., 2001). Some of the
most utilized factors, with proven effects, are transforming
growth factor beta (TGF-), insulin-like growth factor I
(IGF-I) (Walsh et al., 2004) and bone morphogenic
proteins (BMP) (Fei et al., 2006). Other, such as fibroblast
growth factor-2 (FGF-2) (Tsai et al., 2007) and growth
differentiation factor-5 (GDF-5) (Chujo et al., 2006), have
also been shown to be promising –although not so widely
employed in the IVD. The study of the effects of such
growth factors requires not only substantial evaluation in
the laboratory, but translation of their use for the purpose
of regenerative medicine will require regulatory
permission for their clinical use, which is another huge
investment. The legal limitations and high costs of the
growth factors can be even now be a bottleneck stage for
laboratories that investigate the potential of regenerative
disc repair in humans. They will certainly become a huge
burden for national health care systems once the stage of
medical innovation translates into routine clinical
applications. Therefore, it would be beneficial to find
readily available substitutes for these growth factors,
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namely molecules, which will allow cells for autologous
and allogenic transplantation to be optimized, for their
extracellular matrix production, with the potential to be
used later in clinical practice without regulatory problems.
Thus, we tested bioactive, readily available molecules
that had modes of action in two directions: (1) to protect
against cell death – i.e., to preserve or increase the number
of cells in a given sample (considering the limited number
of viable donor cells); (2) to use the differentiation potential
of the – thus-expanded – disc cells in order to attain the
physiological, functional and biological properties of disc
tissue (e.g., preserve and stimulate the ability of cells to
produce and accumulate extracellular matrix).
Here we tested the ability of three molecules –
dexamethasone, insulin and triiodothyronine – to stimulate
cell proliferation and proteoglycan synthesis in
degenerated disc cells embedded in three-dimensional
cultures, under normoxic and hypoxic conditions. Our
selection criteria were based on the molecules’ bioactive
in vitro and in vivo properties, affordability and approval
for clinical use. Dexamethasone, a synthetic
glucocorticoid, is widely used in the medical practice for
its anti-inflammatory properties. It has been demonstrated
to stimulate chondrogenesis in chondrocytes (Grigoriadis
et al., 1989; Quarto et al., 1992; Quarto et al., 1997; Na et
al., 2006) and, together with TGF-, in mesenchymal stem
cells (MSCs) (Johnstone et al., 1998; Derfoul et al., 2006).
Insulin’s multiple functions in the organism include
stimulation of the glucose uptake and the catabolism of
carbohydrates, but it also promotes protein biosynthesis
and chondrocyte proliferation (Quarto et al., 1992; Dever,
2002, Phornphutkul et al., 2006). Triiodothyronine (T3),
an iodine-containing hormone secreted by the thyroid
gland, regulates development, stimulates oxidative
metabolism (Hanken et al., 1988) and has been shown to
play a role in the differentiation of chondrocytes (Quarto
et al., 1992; Kawaguchi et al., 2005).
In the present study, using TGF-1 as a positive control,
we assessed the three molecules for their mitogenic
potential upon cells – by measuring total DNA
concentration and their differentiation abilities, by means
of a proteoglycan accumulation assay, histological and
immunohistochemical analysis and determining the up-
regulation of the transcription of the extracellular matrix
genes, collagen type II and aggrecan.
Materials and Methods
Isolation and culture of human disc cells
Disc cells were isolated from human disc tissue (n=5),
obtained after full or partial discectomy (Table 1) and
approval by a local ethics committee. Disc fragments were
sequentially digested with: (1) 0.3% pronase (Sigma-
Aldrich, St. Louis, MO, USA), 10% fetal bovine serum
(FBS), penicillin (100 units/mL) & streptomycin (100 mg/
mL) in DMEM/F12 + GlutaMAX (all GIBCO) for 1 h at
37°C; (2) 0.05% collagenase (Sigma-Aldrich), 10% FBS,
penicillin (100 units/mL) & streptomycin (100 mg/mL) in
DMEM/F12 + GlutaMAX for 14 h at 37°C. The cell
populations for two donors were mixed, because annulus
fibrous (AF) and nucleus pulposus (NP) could not be
distinguished at this stage of degeneration, during the
surgical procedure.
Disc cells were expanded in culture for 20 days (two
passages) – as a monolayer in DMEM/F12 + GlutaMAX,
supplemented with 10% FBS, penicillin (100 units/mL)
& streptomycin (100 mg/mL), 2.5 ng/ml Amphotericin B
(Gibco, Paisley, UK) and 5 ng/ml recombinant bFGF
(Peprotech, Rocky Hill, NJ, USA) at 37°C in a humid
atmosphere containing 5% CO
2
, with media changed 3
times a week. Cells were then encapsulated in three-
dimensional 1.2 % alginate bead culture at 4,000,000 cells/
mL density (each bead having approximately 80,000 cells).
Alginate (Fluka/Sigma-Aldrich) was selected as a suitable
matrix material because of comparable performance to
agarose (Almqvist et al., 2000; Diduch et al., 2000), while
avoiding the heat shock associated with agarose beads.
Beads, loaded with cells, were cultured for up to 6 weeks
in the presence of 40 ng/ml dexamethasone, 10 nM
triiodothyronine or 10 g/ml insulin (all Sigma-Aldrich)
– added to the basal medium (10% FBS, 50 g/ml ascorbate
(AppliChem, Darmstadt, Germany), penicillin (100 units/
mL) & streptomycin (100 mg/mL) and 2.5 ng/ml
Amphotericin B).  Parallel cultures were also run as
negative (just basal medium) and positive control (basal
medium + 10 ng/mL TGF-1 (Peprotech)). Beads were
sampled in triplicate on a weekly basis.
As a further control, disc cells were cultured in an
optimized chondrogenic medium (10% FBS, 10 ng/mL
TGF-1, 50 g/ml L-proline (AppliChem), 1X Insulin (10
g/ml), Transferrin (5.5 g/ml), Selenium (0.67 ng/ml),
X Supplement (ITS, Gibco), 40 ng/ml dexamethasone, 50
g/ml ascorbate, penicillin (100 units/mL) & streptomycin
(100 mg/mL), 2.5 ng/ml Amphotericin B) and its negative
control (10% FBS, 1X ITS, 50 g/ml ascorbate, penicillin
(100 units/mL) & streptomycin (100 mg/mL), 2.5 ng/ml
Amphotericin B).
Hypoxic cultures of beads
Separately, alginate beads were cultured in media
containing dexamethasone, triiodothyronine, insulin or
TGF-1 for 42 days, under hypoxic conditions. Hypoxia
was achieved, using a reduced oxygen concentration (2%
O
2
 at 37°C in humidified atmosphere, Life Imaging
Service, hypoxia chamber, # 922177, Basel, Switzerland).
Glycosaminoglycan (GAG) accumulation and DNA
assays.
Proteoglycan accumulation was quantified using an alcian
blue binding assay, after overnight digestion of three
alginate beads per sample at 60°C with 125 g/ml papain
(Sigma-Aldrich) in 5 mM L-cysteine-HCl (Sigma-
Aldrich), 5 mM Na-citrate, 150 mM NaCl, 5 mM EDTA
(all AppliChem). GAG accumulation was determined by
its binding to alcian blue (Fluka): absorption was measured
at 595 nm and quantified against chondroitin sulfate
(Sigma-Aldrich) reference standards (Bjornsson et al.,
1993).
Total double stranded DNA was measured for each
sample, after papain digestion – as previously described.
The amount of DNA was determined using SYBR green
(Invitrogen) fluorescent assay (absorption measured at 535
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nm), quantified by referring to calf thymus DNA (Sigma-
Aldrich) standards. All test groups were analyzed in
triplicate.
RNA isolation and quantitative PCR
RNA isolation from the alginate beads was performed at
day 7, 14, 28 and 42 and then stored at -80ºC. RNA was
isolated using Aurum Total Mini Kit (Bio-Rad, Hercules,
CA, USA), adding 2 l polyacryl carrier and following
the manufacturer’s instructions. 500 ng of total RNA were
used for synthesis of cDNA (iScript cDNA Synthesis Kit,
Bio-Rad). cDNA was diluted 1:10 with PCR grade water
and the resulting complementary DNA template (5 l) was
mixed with the PCR reaction solution (IQ SYBR Green
Supermix, Bio-Rad) containing 0.25 M specific primers
– as described in table 2. Specific products (GAPDH,
aggrecan and collagen type II) were amplified by a
quantitative PCR system (CFX96™ Real Time System,
Bio-Rad). Real time PCR was carried out with the
following settings: denaturation 95°C for 3 min (1 cycle),
95°C for 15 s, 64°C for 20 s and 72°C for 20 s (40
amplification cycles), followed by a melting curve analysis.
PCR reactions were carried out in triplicate in a final
volume of 25 l in 96-well plates (Bio-Rad). The results
were normalized to the expression of GAPDH.
Immunohistochemistry and histological analysis
Beads were harvested after 42 days of culture in all the
media, in normoxic and hypoxic cultures, embedded in
OCT Tissue Tek compound for 30 min and then frozen at
-80ºC. Constructs were subsequently cryo sectioned at 30
m thickness using a cryostat (CM 1850, Leica, Wetzlar,
Germany).
Immunohistochemical analysis was used to detect
collagen type II accumulation. Endogenous peroxidases
were quenched by 3% H
2
O
2
 in 0.1 mM CaCl
2
 at room
temperature for 10 min, washed with CaCl
2
 and then
incubated for 40 min with 2500 U/mL hyaluronidase
(Sigma-Aldrich) in 0.1 mM CaCl
2
 at 37°C. Non-specific
background was blocked with PBS containing 1 mg/mL
BSA, 10% FBS and 0.1% Triton (Applichem) for 30 min.
Sections were incubated overnight at 4ºC with monoclonal
mouse anti-collagen type II antibody (1:20; II-II6B3,
Developmental Studies Hybridoma Bank, Ames, IA, USA)
in blocking solution. After washing with 0.1 mM CaCl
2
,
sections were incubated with a secondary biotinylated goat
anti-mouse antibody (1:200; B0529, Sigma-Aldrich), and
then with streptavidin-peroxidase polymer (1:200; S2438,
Sigma-Aldrich) for 45 min at room temperature. Collagen
type II was visualized by reaction with 0.075% solution
of 3-amino-9-ethylcarbazole (AEC, Applichem) in 0.01%
H
2
O
2
. Sections were mounted with 70% glycerol
(Applichem) and examined by light microscopy.
Histological detection of GAG accumulation was
carried out by alcian blue staining. Sections were stained
overnight with 0.4% alcian blue, dissolved in 0.01% H
2
SO
4
(Applichem) and 0.5M guanidine hydrochloride (Fluka).
Next, sections were washed for 30 min in 40% DMSO
and 0.05M MgCl
2 
(both from Applichem), mounted with
70% glycerol and examined by light microscopy.
Statistics
The Wilcoxon non-parametric test for dependent variables
was used to compare gene expression, DNA quantification
and GAG accumulation. Values are reported as mean ±
SD. Data analysis was performed with SPSS 14.0 for
Windows (SPSS Inc., Chicago, IL, USA) and a
significance value of p<0.05 was specified.
Sample Sex 
Donor’s age 
(Years) 
Type of 
Sample 
Thompson 
Grading Scale 
1 F 44 NP IV 
2 F 47 AF II T
3 F 47 NP II T
4 M 50 MD III 
5 M 52 MD II 
Gene Primer nucleotide sequence (5’ to 3’) Pr
GAPDH F - TGGACTCCACGACGTACTCA 
 R - GGAAGCTTGTCATCAATGGAA 
Aggrecan F - AGGCTATGAGCAGTGTGAACG 
 R - GCACGCCATAGGTCCTGA 
Collagen Type II F - GAAGTGCTGGTGCTCGTG 
 R - GGCCTCTCCTTGCTCACC 
Table 1. Demographic details of donors (Average age = 48)
Table 2. Human marker genes used in quantitative RT-PCR. (F = Forward, R = Reverse).
AF = Annulus Fibrosis; NP = Nucleus Pulposus; MD = Mixed Disc; DDD = Degenerated Disc Disease.
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Fig. 1. DNA quantification of IVD cells in three-dimensional alginate bead cultures in T3, insulin, dexamethasone,
TGF-1, ITS and chondrogenic media over 42 days (A) effect on GAG accumulation per bead (B) and normalized
to DNA (C) by IVD cells in the same samples. (Values represent the triplicate mean ± standard deviation; * = p<0.05
compared to basal medium of the respective time point, * above bar  = p<0.05 within the group [time course]).
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Results
Effects of dexamethasone, insulin, and T3 on cell number
Double stranded DNA content was measured for all
samples in order to estimate cell number (Fig. 1A). At day
42 there was an overall trend of constant decrease (average
37% ±11%, compared to day 7) of human disc cells
survival – except in the chondrogenic medium, where DNA
concentration from day 14 was stable and significantly
higher compared to other media. This was also partially
observed in the dexamethasone group, where an absolute
– but non-significant – increase was observed until day
28, followed by a drop by day 42. However, compared to
basal medium at day 42, cells in the dexamethasone-treated
group showed a significant increase of 75.3% (p<0.05)
and approximately of 30% for the TGF-1-group (p<0.05).
Similar 30%, however – non significant, increase was
measured for the ITS-treated group.
Effects of dexamethasone, insulin, and T3 on GAG
accumulation
Human disc cells showed a clear trend of time-dependent
increase of GAG accumulation (Fig. 1B), except for cells
grown in T3-supplemented medium (when GAG was
normalized per bead). The overall accumulation of GAG
by human cells, after 42 days of culture, showed a
significant four-fold increase over the basal medium in
the TGF-1-treated group (p<0.05) and an approximately
two-fold increase for the dexamethasone-treated group
(p<0.05), while there was no significant changes induced
by insulin and T3. In particular, in the group treated with
TGF-1, there was already a constant significant increase
of up to 42% (p<0.05) in GAG concentration, compared
to basal medium, after one week. In contrast, in the
dexamethasone- and ITS-treated groups, a significant
increase was observed only after 14 and 28 days,
respectively. As a positive control, the group cultured in
Fig. 2. Gene expression of collagen type II (A) and aggrecan (B) by IVD cells in alginate beads cultured in different
media. Quantitative RT-PCR analysis (Relative expression normalized to GAPDH and to basal medium at day 7,
represented as a mean ± SD, * = p<0.05 compared to basal medium of the respective time point, * above bar  =
p<0.05 within the group [time course]).
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optimized chondrogenic medium accumulated a
significantly greater amount of GAG compared to basal
medium, showing an approximately seventeen-fold
increase after 42 days (p<0.05). However, if GAG
accumulation was normalized to DNA, only TGF-1 and
chondrogenic-treated groups were constantly stimulating
IVD cells’ production of GAG significantly during the
whole course of the experiments (Fig. 1C). Compared to
basal medium at day 42, cells showed a significantly
increased 7 fold GAG accumulation in the chondrogenic
group (p<0.05), 3 fold increase in the TGF-1-group
(p<0.05) and approximately 2 fold increase in ITS-treated
group (p<0.05), while no significant effects were observed
in the other media.
Real-time quantitative PCR
Quantitative PCR of collagen type II (Fig. 2A) and
aggrecan (Fig. 2B) in human disc cells cultures, treated
with the different media, were compared to the basal
medium at different time points. Collagen type II expression
increased with time in all media, but only in the TGF-1-
, ITS- and chondrogenic- supplemented groups there was
a significant increase (p<0.05) compared to the basal
medium. Interestingly, the TGF-1 supplementation
showed a major increase of collagen type II expression in
the first 14 days of culture, while ITS was more effective
at day 28 and 42. The greatest significant increase (p<0.05)
compared to the basal media (755 fold at day 42) was in
the chondrogenic group.
Aggrecan gene expression also showed a time-
dependent increase in all groups, except in the TGF-1-
treated group where, following 14 days, the number of
RNA copies stabilized for the remainder of the experiment.
Surprisingly, the dexamethasone group was the only one
where gene expression of aggrecan was significantly up-
regulated at all time points (p<0.05). Interestingly, the
dexamethasone- and chondrogenic-treated groups had the
highest ratio of aggrecan induction at day 14
(approximately 12-fold increase compared to basal
medium) but at day 42, only dexamethasone- and ITS-
treated cells were significantly upregulating aggrecan
expression (p<0.05).
Comparison of effects of dexamethasone, insulin and
T3 in normoxic and hypoxic cultures
Human disc cells cultured under hypoxic conditions (2%
O
2
) for 42 days showed a significant enhancement of GAG
accumulation in all media (p<0.05), except for the T3-
group (Fig. 3A). In the basal- and dexamethasone-group,
there was a two-fold increase compared to normoxia. In
the case of insulin-treated cells, the increase was four-
fold and GAG accumulation in TGF-1-group under
hypoxia increased by five-fold (200 g/mL, thus identical
to the optimized chondrogenic medium in normoxia). Cell
viability under hypoxic conditions, represented by total
DNA amount, showed a significant reduction in all the
media, except in basal- and TGF-1-treated cells (Fig. 3B).
In particular, DNA showed a reduction of almost 30% in
Fig. 3. Comparison between normoxic and hypoxic cultures of disc cells in three-dimensional alginate bead cultures.
Comparison was performed analyzing: GAG accumulation (A), DNA amount (B), collagen type II (C) and aggrecan
gene expression (D). Analyses were conducted after 42 days of culture. (Relative expression normalized to GAPDH
and to basal medium under normoxic conditions, represented as a mean ± SD, * = p<0.05 compared to basal medium
in normoxia, * above bar = p<0.05 within the group).
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the insulin- and dexamethasone-treated groups (p<0.05)
and by 20% in the T3-treated groups (p<0.05).
Collagen type II expression was significantly enhanced
by hypoxia in all groups (p<0.05) (Fig. 3C). Particularly
impressive, the cells in the basal media group had an
approximately 80 fold increase compared to the same
group in normal oxygen conditions. Within the other
groups, collagen type II expression went up on average
seven fold. Aggrecan gene expression also increased under
hypoxia, but only in basal-, dexamethasone and TGF-1-
treated groups was the increase significant (Fig. 3D,
p<0.05). As in the case of collagen type II, cells cultured
in basal medium had the highest relative increase within
the group (eleven-fold compared to normoxic culture).
Meanwhile cells in the other groups showed an average
threefold increase.
Histological and immunohistochemical staining
The quantitative data for GAG accumulation was
confirmed in all groups by histological staining of alginate
bead sections with alcian blue at 42 days of culture (Fig.
4A). In normoxia, staining of dexamethasone-treated beads
was higher compared to T3- and insulin-treated groups,
but still lower than with TGF-1. Hypoxia was a major
inducing factor for accumulation of GAG, to the extent
that both TGF-1-treated and dexamethasone groups
showed staining comparable to that of the fully optimized
chondrogenic culture in normoxia. A very intensive blue
staining, indicating strong GAG production was observed
directly around the cells, especially in the case of the
chondrogenic group.
The localization of collagen type II in bead sections
was determined by immunostaining under normoxic and
hypoxic conditions after 42 days in culture (Fig. 4B). As
expected, collagen type II accumulation was highest in
the chondrogenic group, and almost undetectable in other
groups, except in the TGF-1-treated beads.
Discussion
This study had the practical purpose of testing readily
available bioactive molecules, which are widely used in
clinical practice, as a substitute to expensive, unapproved
or proprietary growth factors. Three molecules were
hypothesized to preserve or enhance cell survival and
extracellular matrix synthesis of primary disc cells isolated
from degenerated intervertebral tissue. IVD cells were
isolated from mildly to moderately degenerated tissues
(Thompson grades 2-3) and in one case from a highly
degenerated tissue (Thompson grade 4). Irrespective of
the grade of degeneration, all IVD cells responded to T3,
insulin, dexamethasone, TGF-1 and ITS supplementation.
We advocate that GAG accumulation assay data in this
particular case were normalized per bead and not to total
DNA, as commonly done, for the following reasons: firstly,
alginate beads had, initially, the same cell number (hence
DNA content); secondly, we were interested in the total
deposition of GAG in the extracellular matrix and
normalization to DNA at different time points would bias
the GAG amount to appear greater in groups where there
is decreased DNA (control, T3, insulin), i.e., cell death.
We can see that when GAG accumulation assay data were
Fig. 4. Microphotographs of alginate beads sections stained with alcian blue after 42 days of culture (A). The
deposition of proteoglycan-rich extracellular matrix is defined by increase in the blue staining. On the bottom panel,
immunohistochemical analysis of collagen type II (B). Positive staining is indicated by the spotted red-colored
extracellular matrix. Cellular morphology shows differences among the groups (All scale bars are 125 m).
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normalized to total DNA the sensitivity of the method is
reduced when the supplementing factors are affecting the
cell number.
As expected for fully differentiated disc cells, all
groups, including those in the negative control (basal
medium, no added growth factors) showed a trend of
increased GAG synthesis with time. Cells treated with
dexamethasone and TGF-1 produced more GAG per bead
compared to the insulin, T3 and basal medium groups, after
14 days in culture. However, the effect of dexamethasone
on GAG accumulation by IVD cells is lower and not
significant when normalized to DNA, due to the large
number of cells retained per bead. In the chondrogenic
medium, the synergistic effect of TGF-1, dexamethasone
and insulin (as part of ITS) provided a superior effect
compared to the results obtained for the single molecules.
Among the molecules tested, dexamethasone was the only
one able positively to affect cell survival. Indeed, the only
other medium that had a positive effect on cell survival
was the chondrogenic medium (containing
dexamethasone). Cell proliferation was affected neither
by insulin nor by T3, rendering T3 as the least active of
the tested molecules.
The ability of dexamethasone to enhance extracellular
matrix synthesis was also tested both by analysis of
aggrecan and collagen type II gene expression, and it
proved to be the only molecule that significantly stimulated
the expression of aggrecan during the whole experimental
period. In contrast, the chondrogenic medium, which
contains dexamethasone, had a significant effect on
aggrecan production only in the first two weeks.
Interestingly, TGF-1 alone did not affect aggrecan
expression – and in the last week reduced the expression
below that detected in basal medium. This result could
explain why, in respect to aggrecan expression,
chondrogenic medium was not performing as well as the
dexamethasone-only medium. On the other hand, the major
role of dexamethasone in aggrecan expression was not
reflected by positive correlation with collagen type II gene
expression. The absence of a proper collagen network,
which can contain other extracellular matrix molecules,
could be the main reason for the low accumulation of GAG,
when measured by the alcian blue assay. In the case of
collagen type II expression, both insulin and ITS played
important roles. ITS supplementation stimulated COL2
significantly compared to basal medium and had a
comparable effect to that of TGF-1 alone, while the effects
of other molecules were not significantly different from
basal medium. While, collagen type II expression was
induced strongly by TGF-1 during the first two weeks of
culture, insulin had a delayed action and was more effective
in the final weeks. This might be because of insulin’s
similarity to insulin-like growth factor-I (IGF-I), and its
ability to bind to the IGF-I receptor (Quarto et al., 1992;
Kawaguchi et al., 2005). Even at lower concentrations, at
which insulin does not bind to the IGF-I receptor, it can
act as a proliferative and differentiating chondrogenic agent
(Phornphutkul et al., 2006), thus stimulating collagen type
II expression. It should be stressed, especially in the case
of collagen type II expression, that the expression levels
obtained by chondrogenic medium were much higher than
the sum of using single molecules added to basal medium.
This leads to the important conclusion that synergistic
results can be obtained when growth factors are combined
in a chondrogenic cocktail and demonstrates the complex
needs of IVD cells for appropriate signaling. However, in
the case when some of these growth factors were already
synthesized to satisfactory levels in vivo, stimulatory action
can be achieved only by adding the missing ones.
Hypoxia proved to improve proteoglycan accumulation
significantly in all media, except in the T3 treated group,
while cell viability was equal or even lower in hypoxia
compared to normoxia. The general increase of GAG in
the extracellular matrix was mirrored also by an increase
in gene expression of collagen type II. Aggrecan gene
expression was increased only in the basal and TGF-1
media, but the incubation in hypoxic conditions greatly
increased proteoglycan accumulation in the TGF-1 group
to values identical to those of chondrogenic medium in
normoxia, thus “compensating” for the lack of
dexamethasone and insulin. Also remarkably, hypoxia
combined with insulin- and dexamethasone-supplemented
media stimulated GAG accumulation to a greater level than
TGF-1 in normoxic conditions.
Since the aim of this study was to evaluate whether
readily available bioactive molecules could be used for
stimulation and activation of isolated IVD cells and their
further re-implantation in vivo, it is important to mention
known limitations of the used molecules. Dexamethasone
and T3 have been shown to induce hypertrophic
differentiation in chondrocytes and endochordal
ossification in culture (Quarto et al., 1992; Miura et al.,
2002). Additionally, the use of 10% serum is not suitable
for clinical application; however at lower serum
concentrations a greatly increased cell death occurs after
more than two weeks in cultures which are not
supplemented with growth factors, therefore excluding the
use of important controls. However, the ongoing efforts
in the development of serum-free media (the topic of other
studies) should solve this problem. As a conclusion, we
could show that dexamethasone is a valuable, readily
available molecule for maintaining cell survival and
induction of proteoglycan synthesis in human disc cells,
which has a strong synergistic effect together with TGF-
1 and ITS, resulting in a dramatic improvement of the
GAG content. Valuable but somewhat unexpected results
were also obtained in hypoxic culture, where insulin- and
dexamethasone-treated cells produced a greater amount
of proteoglycan than TGF-1-treated cells in normoxic
culture, suggesting not only a possible application of these
medically approved molecules for research but also in the
hypoxic IVD environment in vivo. As a next step, these
molecules will be also tested in an established ex-vivo,
whole organ, disc degeneration model (Haschtmann et al.,
2006a,b) to investigate the effects of those molecules on a
higher organizational level.
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